Asahi Kasei Bioprocess is the established global market leader in virus filtration products, with its Planova virus removal filters having an unrivalled 30 years history of trusted use in the production of biotherapeutics, such as biopharmaceuticals and plasma derived drug products.
Pall Biotech can provide fully integrated bioprocessing solutions for gene therapy, from discovery through to commercialization; from upstream through to final filling; from initial design through to implementation.
With a range of solutions covering multiple virus types, and with production in either adherent or suspension processes, our extensive single-use portfolio can offer you the complete solution you need.
PathoQuest offers biopharmaceutical companies a game changing Genomic approach to secure the biosafety of biological drugs like cell & gene therapy products, vaccines and recombinant. It allows to reduce time to market of innovative treatments.
PathoQuest’s technology combines a Next-Generation Sequencing (NGS) platform with a proprietary sample preparation processes completed by a proprietary pathogen genome sequence databases and automated analysis pipeline.
Solentim is a Life Sciences company committed to transforming the discovery and development of new biologics. As the global leader in accelerating cell line development through intelligent automation, we create practical solutions to speed up workflows and improve productivity. We present a platform of connected instruments from Solentim and reagents from our collaborators covering transfection to outgrowth and early clone attributes.
Our core products are the Cell Metric® range of bright field whole well imaging stations and the VIPS™ (Verified In-situ Plate Seeding) which combine high efficiency automated single cell seeding with imaged based analytical assurance of clonality, with documented proof of clonal origin.
G-CON Manufacturing designs, builds and installs prefabricated cleanroom PODs. G-CON’s cleanroom POD portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. The POD cleanroom units surpass traditional cleanroom structures by virtue of their scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end.
Asgard is a high growth, progressive EMEA Company established in 2000. We are the leader in Modular Cleanroom Design for the Biotech & Pharma sector. We supply and focus on the design, manufacture and construction of innovative Biotech and Pharmaceutical controlled environment solutions. Asgard is a respected expanding European brand providing a single source for the successful implementation of Biotechnology & Pharmaceutical projects from concept design through to deliverable completion. Asgard has successfully delivered over 85,000m2 of cleanroom space from 2015 – YTD across Europe with Cleanrooms ranging from ISO 5 – ISO 8 classifications.
Please see hyperlink: http://www.asgardcleanrooms.com/
Pneumatic Scale Angelus is a manufacturer of continuous flow centrifuges for the biotech industry. The brands Centritech and CARR are well known in the industry for many years. Our main focus during the last years has been in the single-use centrifuges, offering the Centritech Lab III and CELL 8 for perfusion cell cultures at any scale and the UniFuge® Single-use Separation System for vaccine, stem cell and monoclonal antibody manufacturing. PSA now offers the U2k® Single-use Separation System for cell culture harvesting up to 2000 liters.
Pneumatic Scale Angelus is also the manufacturer of the CARR Powerfuge® and ViaFuge®. Both machines are industrial stainless steel continuous flow centrifuges, available in various sizes. While the ViaFuge® is used for mammalian cell separation, the Powerfuge® is our high G model for solid liquid separation.
Cytena is a life-science company focusing on single cell technologies, and a part of the CELLINK Group. cytena was founded in 2014 within the Institute for Microsystems Technology (IMTEK) at the University of Freiburg, and primarily sells high-precision solutions for handling biological cells. The cytena team has developed a patented single-cell printer™ technology, which enables users to isolate and dispense single cells in a documented, gentle and sterile process. The single-cell printers have been manufactured in Germany since 2015 and are marketed worldwide. In 2018, the x.sight™ series was added to the company’s product portfolio. Most top ten pharmaceutical companies use cytena’s single-cell printers to produce clonal cell lines for manufacturing antibodies.
Invest in Denmark provide tailor-made solutions for foreign companies looking to set up or expand business or research activities in Denmark.
Our services: Invest in Denmark provides confidential and tailor-made solutions for foreign companies looking to set up a new business in Denmark or expand an existing one.
Visit the website here https://biopharma-asia.com/
BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.